Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Adjusted in-hospital clinical outcomes associated with left atrial appendage occlusion utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Patient, operative and hospital characteristics stratified by utilization of left atrial appendage occlusion (LAAO) during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Unadjusted in-hospital clinical and financial outcomes stratified by utilization of left atrial appendage occlusion (LAAO) during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Mean (standard deviation) of weight loss rate for all groups incubated with and without collagenase and hydroxyproline (Hyp) release of dentin samples subjected to collagenase degr... by Flaviana Alves Dias (10439927)

Subjects:

Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Flow chart of the study participants. by Oscar F. C. van den Bosch (22184246)

Subjects:

Effects of s-ketamine and midazolam on respiratory parameters. by Oscar F. C. van den Bosch (22184246)

Subjects:

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Linear trends of the total annual, winter, and monsoon precipitation in the northern high lands of Pakistan during 1990 to 2020. by Abdulnoor Ali Jazem Ghanim (16764644)

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)